136 related articles for article (PubMed ID: 30543826)
1. Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles.
Liu M; Liang G; Zheng H; Zheng N; Ge H; Liu W
Life Sci; 2019 Jan; 217():222-228. PubMed ID: 30543826
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of drug resistance in smoothened receptor: An in silico study of protein resistivity and specificity.
Sinha N; Chowdhury S; Sarkar RR
Proteins; 2020 Mar; 88(3):514-526. PubMed ID: 31589795
[TBL] [Abstract][Full Text] [Related]
3. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J
Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493
[TBL] [Abstract][Full Text] [Related]
4. Smoothened stimulation by membrane sterols drives Hedgehog pathway activity.
Deshpande I; Liang J; Hedeen D; Roberts KJ; Zhang Y; Ha B; Latorraca NR; Faust B; Dror RO; Beachy PA; Myers BR; Manglik A
Nature; 2019 Jul; 571(7764):284-288. PubMed ID: 31263273
[TBL] [Abstract][Full Text] [Related]
5. Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors.
Teske KA; Dash RC; Morel SR; Chau LQ; Wechsler-Reya RJ; Hadden MK
Eur J Med Chem; 2019 Feb; 163():320-332. PubMed ID: 30529635
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity.
Zhang H; Sun Z; Liu Z; Song C
Future Med Chem; 2018 Dec; 10(24):2855-2875. PubMed ID: 30557039
[TBL] [Abstract][Full Text] [Related]
7. Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo.
Tian N; Wu H; Zhang H; Yang D; Lv L; Yang Z; Zhang T; Quan D; Zhou L; Xie Y; Xu Y; Wei N; Zhang J; Chen M; Schmitz JC; Tian Y; Wu S
Bioorg Med Chem; 2020 Aug; 28(16):115584. PubMed ID: 32690258
[TBL] [Abstract][Full Text] [Related]
8. Comment on: Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles.
Kozielewicz P
Life Sci; 2019 May; 225():132. PubMed ID: 30965054
[No Abstract] [Full Text] [Related]
9. Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.
Kim J; Aftab BT; Tang JY; Kim D; Lee AH; Rezaee M; Kim J; Chen B; King EM; Borodovsky A; Riggins GJ; Epstein EH; Beachy PA; Rudin CM
Cancer Cell; 2013 Jan; 23(1):23-34. PubMed ID: 23291299
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand.
Zhang X; Zhao F; Wu Y; Yang J; Han GW; Zhao S; Ishchenko A; Ye L; Lin X; Ding K; Dharmarajan V; Griffin PR; Gati C; Nelson G; Hunter MS; Hanson MA; Cherezov V; Stevens RC; Tan W; Tao H; Xu F
Nat Commun; 2017 May; 8():15383. PubMed ID: 28513578
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of Smoothened Activation in Hedgehog Signaling.
Huang P; Zheng S; Wierbowski BM; Kim Y; Nedelcu D; Aravena L; Liu J; Kruse AC; Salic A
Cell; 2018 Jul; 174(2):312-324.e16. PubMed ID: 29804838
[TBL] [Abstract][Full Text] [Related]
12. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
[TBL] [Abstract][Full Text] [Related]
13. State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures.
Espinosa-Bustos C; Mella J; Soto-Delgado J; Salas CO
Future Med Chem; 2019 Mar; 11(6):617-638. PubMed ID: 30912670
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Interaction Sites on the Transmembrane Domain of the Hedgehog Signal Transducer and Class F G Protein-Coupled Receptor Smoothened.
Hedger G; Koldsø H; Chavent M; Siebold C; Rohatgi R; Sansom MSP
Structure; 2019 Mar; 27(3):549-559.e2. PubMed ID: 30595453
[TBL] [Abstract][Full Text] [Related]
15. "Hedgehog pathway": a potential target of itraconazole in the treatment of cancer.
Wei X; Liu W; Wang JQ; Tang Z
J Cancer Res Clin Oncol; 2020 Feb; 146(2):297-304. PubMed ID: 31960187
[TBL] [Abstract][Full Text] [Related]
16. Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs.
Kaboli PJ; Bazrafkan M; Ismail P; Ling KH
Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):384-400. PubMed ID: 28969581
[TBL] [Abstract][Full Text] [Related]
17. A molecular dynamics approach to identify an oxysterol-based hedgehog pathway inhibitor.
Dash RC; Maschinot CR; Hadden MK
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):168-177. PubMed ID: 27825830
[TBL] [Abstract][Full Text] [Related]
18. Sterols in an intramolecular channel of Smoothened mediate Hedgehog signaling.
Qi X; Friedberg L; De Bose-Boyd R; Long T; Li X
Nat Chem Biol; 2020 Dec; 16(12):1368-1375. PubMed ID: 32929279
[TBL] [Abstract][Full Text] [Related]
19. Activation mechanism of the human Smoothened receptor.
Bansal PD; Dutta S; Shukla D
Biophys J; 2023 Apr; 122(7):1400-1413. PubMed ID: 36883002
[TBL] [Abstract][Full Text] [Related]
20. Structural dynamics of Smoothened (SMO) in the ciliary membrane and its interaction with membrane lipids.
Kumari S; Mitra A; Bulusu G
Biochim Biophys Acta Biomembr; 2022 Aug; 1864(8):183946. PubMed ID: 35483421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
